Advances in Dry Eye Disease Treatment

9.3% of adult Americans have been diagnosed or experiencing symptoms of dry eye disease. Authors from Philadelphia focused on various treatment options available. Traditional regimen include over-the-counter artificial tears, warm compresses, and lid hygiene. Recently approved topical agent lifitegrast have promising results in improving dry eye symptoms at least as well as topical cyclosporine. Among in-office procedures, most aim to improve meibomian gland function, primarily by heating. The first approved device to increase tear production is the intranasal tear neurostimulator. It was designed to stimulate the mucosal nerves via small electrical currents to increase natural tear production via the nasolacrimal reflex pathway. Check detailed information in the original article.